Marcum Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $605K | Sell |
1,247
-79
| -6% | -$38.3K | 0.05% | 170 |
|
|
2024
Q4 | $534K | Buy |
1,326
+122
| +10% | +$49.1K | 0.05% | 187 |
|
|
2024
Q3 | $560K | Buy |
1,204
+26
| +2% | +$12.1K | 0.05% | 176 |
|
|
2024
Q2 | $552K | Buy |
1,178
+2
| +0.2% | +$937 | 0.06% | 172 |
|
|
2024
Q1 | $492K | Sell |
1,176
-16
| -1% | -$6.69K | 0.05% | 193 |
|
|
2023
Q4 | $485K | Sell |
1,192
-72
| -6% | -$29.3K | 0.05% | 188 |
|
|
2023
Q3 | $440K | Sell |
1,264
-5
| -0.4% | -$1.74K | 0.05% | 194 |
|
|
2023
Q2 | $447K | Sell |
1,269
-128
| -9% | -$45K | 0.05% | 190 |
|
|
2023
Q1 | $440K | Sell |
1,397
-56
| -4% | -$17.6K | 0.05% | 195 |
|
|
2022
Q4 | $420K | Buy |
1,453
+10
| +0.7% | +$2.89K | 0.06% | 186 |
|
|
2022
Q3 | $418K | Sell |
1,443
-75
| -5% | -$21.7K | 0.06% | 179 |
|
|
2022
Q2 | $428K | Sell |
1,518
-49
| -3% | -$13.8K | 0.06% | 179 |
|
|
2022
Q1 | $409K | Sell |
1,567
-84
| -5% | -$21.9K | 0.06% | 192 |
|
|
2021
Q4 | $363K | Sell |
1,651
-100
| -6% | -$22K | 0.05% | 218 |
|
|
2021
Q3 | $318K | Buy |
1,751
+72
| +4% | +$13.1K | 0.05% | 230 |
|
|
2021
Q2 | $339K | Sell |
1,679
-20
| -1% | -$4.04K | 0.06% | 203 |
|
|
2021
Q1 | $365K | Buy |
+1,699
| New | +$365K | 0.06% | 190 |
|